Karen A. Dawes, Director at REPLIGEN CORP (RGEN), sold 1,550 shares at $227.17 ($352K) on 2022-09-09, disclosed to the SEC on 2022-09-09.
Open-market sale of $352k RGEN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $227.17 | 775 | $176K | 50.0% |
| 2 | $227.17 | 775 | $176K | 50.0% |
| Total | $227.17 avg | 1,550 | $352K | 100% |
| Filing → |
| RGEN | SELL | 2023-08-30 | $146K | — | Filing → |
| RGEN | SELL | 2022-05-26 | $4.4M | — | Filing → |
| RGEN | SELL | 2021-11-12 | $2.5M | — | Filing → |